1. Pfizer's High-Profile Strategy Chief Andrew Baum Exits After 6 Months, Role Eliminated
Pfizer's strategic pivot has hit a sudden reset. Andrew Baum, the former Citi investment banker brought in just six months ago to overhaul the pharmaceutical giant's post-pandemic direction, has abruptly departed his roles as Executive Vice President and Chief Strategy and Innovation Officer. His exit, confirmed by the...